ECJ Medicinal products for human use – Directive 2001/83/EC – Article 77 – Wholesale distribution of medicines – Mandatory special authorisation for pharmacists – Conditions for granting Judges: JN Cunha Rodrigues P Citations: C-7/11, [2012] EUECJ C-7/11 Links: Bailii Statutes: Directive 2001/83/EC 77 European Updated: 03 November 2022; Ref: scu.461894
ECJ Opinion – Human Drugs – Concept advertising – Dissemination of information on a drug by an independent person – Freedom of Expression Judges: Damaso Ruiz-Jarabo Colomer AG Citations: C-421/07, [2008] EUECJ C-421/07 – O Links: Bailii Jurisdiction: European Cited by: Opinion – Anklagemyndigheden v Damgaard ECJ 2-Apr-2009 ECJ Medicinal products for human use Directive … Continue reading Anklagemyndigheden v Damgaard: ECJ 18 Nov 2008
This SPC application concerns the combination of active ingredients, ezetimibe and atorvastatin, found in the medicinal product, ATOZET (RTM). A marketing authorization for ATOZET was being sought under the decentralised procedure (DCP) but, at the date of application for the SPC on 12 September 2014, which was only 1 day before expiry of the patent, … Continue reading Merck Sharp and Dohme Corporation (Patent): IPO 12 Jan 2016
The Claimants complained that the Defendant wrongly refused to treat as medicinal products the large number of GCPs (glucosamine-containing product) described as ‘food supplements’. Held: The claim failed. Supperstone J [2014] EWHC 1679 (Admin), CO/6789/2013 Bailii Directive 2001/83/EC Cited by: Appeal from – Blue Bio Pharmaceuticals Ltd and Another v Secretary of State for Health … Continue reading Blue Bio Pharmaceuticals Ltd and Another, Regina (on The Application of) v Secretary of State for Health (Mhra): Admn 22 May 2014
